About: Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 May 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2010 (uk) im Mai 2010 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2010 (ast) scientific article published on 23 May 2010 (en)
publication date	wds:Q60169777-AE488A1F-DEDB-431E-AEDA-846DCDA43447
publication date	2010-05-23 00:00:00Z (xsd:dateTime)
author name string	wds:Q60169777-04A62D64-3ECA-4E12-BDBF-2FAEE3E04241 wds:Q60169777-37886460-DD11-4495-A1BB-8E27D89DD18F wds:Q60169777-40004E2B-3CB5-4D99-AE0A-B54866621FAB wds:Q60169777-5FF36BB1-611A-4AB2-9B27-A17741849A9A wds:Q60169777-B29F9EA5-1492-4B8E-996A-21318C4CB63B
author name string	K Bencardino M Danova M Manzoni E Villa S Brugnatelli
rdfs:label	Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (en) Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (nl)
skos:prefLabel	Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (en) Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (nl)
name	Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (en) Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (nl)
author	wds:Q60169777-4CD99213-A1A4-4663-91D3-5EC26CCB0574 wds:Q60169777-B682285F-C0A5-46BC-8B66-0987FA0A719C wds:Q60169777-CE80562C-A2A4-4F81-9C22-E9854F4118BD wds:Q60169777-E48D5923-1E32-40B3-B154-6EFC1CACD220 wds:Q60169777-FB7DBD80-D838-479F-880F-4E9376F0EC2E wds:Q60169777-FC033578-BE8B-42BC-A378-2989120377AC
author	Carmine Tinelli Monica Ronzoni Alfredo Falcone Sara Mariucci Bianca Rovati Fotios Loupakis
title	wds:Q60169777-ADF3FC0D-C754-4B4A-ADFF-FC753A058B49
title	Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients (en)
page(s)	wds:Q60169777-E7DFE525-7456-4CA2-9DF6-81AF2779E41D
page(s)	2382-2389
instance of	wds:Q60169777-7EDD1A55-1FC0-40F6-BFB8-B2A71A2B3A81
instance of	scholarly article
main subject	wds:Q60169777-2AD7B7A9-68B2-4642-B187-7481905DEA98 wds:Q60169777-43AA9FEF-89B7-4C1D-B761-FFB03A98E13F wds:Q60169777-ECDE6860-143C-4D99-AD7A-1C71689985A4
main subject	bevacizumab colorectal cancer colorectal carcinoma
PubMed ID	wds:Q60169777-EA0F7B10-3AEA-406D-BBE7-747FDFEBE2CB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20497963
PubMed ID	20497963
published in	wds:Q60169777-EED1CBE2-A891-4A18-89A9-6882C8C24CED
published in	Annals of Oncology
issue	wds:Q60169777-DD1D1566-1DA9-4CC1-A528-BF17CB89674D
volume	wds:Q60169777-0481826E-AE07-4C8B-BBA1-5C01AA04A694
issue	12
volume	21
DOI	wds:Q60169777-61B3911E-C569-4F80-9282-0457A8E7187C
DOI	http://dx.doi.org/10.1093/ANNONC/MDQ261
DOI	10.1093/ANNONC/MDQ261
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60169777
is cites work of	Circulating Tumor Cells and Colorectal Cancer. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy Targeted therapies in colorectal cancer-an integrative view by PPPM Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer Biomarkers in tumor angiogenesis and anti-angiogenic therapy Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. Bevacizumab in the treatment of metastatic breast cancer: friend or foe? Controlling escape from angiogenesis inhibitors Biomarkers to predict the clinical efficacy of bevacizumab in cancer A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas Circulation of progenitor cells in obese and lean colorectal cancer patients KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials Targeting angiogenesis in esophagogastric adenocarcinoma Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab Biomarkers for anti-angiogenic therapy in cancer. Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan From bench to bedside: lessons learned in translating preclinical studies in cancer drug development A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients. Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome. Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. Prognostic value of circulating endothelial cells in metastatic colorectal cancer Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation Endothelial cells in colorectal cancer Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients. Optimized multiparametric flow cytometric analysis of circulating endothelial cells and their subpopulations in peripheral blood of patients with solid tumors: a technical analysis. Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer [Predictive biomarkers for bevacizumab in anti-tumor therapy]. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma Biomarkers in advanced colorectal cancer: challenges in translating clinical research into practice
is cites work of	wds:Q39263457-C9C972AE-3C81-4301-83E3-14AB6B1E60CD wds:Q53641435-04AA2042-7903-43A3-87E8-37089AF63F2F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software